LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

Search

Bio-Techne Corp

Gesloten

SectorGezondheidszorg

49.46 0.43

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

48.36

Max

49.88

Belangrijke statistieken

By Trading Economics

Inkomsten

-12M

23M

Verkoop

19M

316M

K/W

Sectorgemiddelde

64.94

56.602

EPS

0.56

Dividendrendement

0.64

Winstmarge

7.144

Werknemers

3,100

EBITDA

-36M

39M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+46.92% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.64%

2.45%

Volgende Winsten

6 aug 2025

Volgende dividenddatum

30 mei 2025

Volgende Ex Dividend datum

18 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-2B

8.5B

Vorige openingsprijs

49.03

Vorige sluitingsprijs

49.46

Nieuwssentiment

By Acuity

50%

50%

198 / 382 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

Bio-Techne Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 mei 2025, 20:40 UTC

Acquisities, Fusies, Overnames

FedEx Names CEO, Chairman for Planned Freight Spinoff

20 mei 2025, 00:00 UTC

Top Nieuws

America's Fiscal Situation Threatens the Good Mood on Wall Street -- WSJ

19 mei 2025, 23:48 UTC

Marktinformatie

Nikkei May Rise as Fears About Moody's U.S. Downgrade Ease -- Market Talk

19 mei 2025, 23:43 UTC

Marktinformatie

Gold Edges Lower on Possible Technical Correction -- Market Talk

19 mei 2025, 23:22 UTC

Top Nieuws

Crypto Billionaire Accused of Defrauding Creditors, Propelling Industry's 2022 Collapse -- WSJ

19 mei 2025, 22:33 UTC

Marktinformatie

Uranium Buyers Could Accelerate Restocking -- Market Talk

19 mei 2025, 22:16 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Use Divestment Proceeds for Business Development Purposes

19 mei 2025, 22:16 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Sell Stake for CNY4.15B

19 mei 2025, 22:15 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Sell Stake to China Resources Land

19 mei 2025, 22:15 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Sell 65% Stake in Beijing Haizhen Real Estate

19 mei 2025, 22:02 UTC

Winsten

Trip.com Group 1Q Rev $1.9B >TCOM

19 mei 2025, 22:02 UTC

Winsten

Trip.com Group 1Q Adj EPS 82c >TCOM

19 mei 2025, 22:02 UTC

Winsten

Trip.com Group 1Q EPS 84c >TCOM

19 mei 2025, 21:58 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

19 mei 2025, 21:58 UTC

Marktinformatie

Global Equities Roundup: Market Talk

19 mei 2025, 21:58 UTC

Marktinformatie

Automakers to Raise Prices by End of June, Toyota COO Says -- Market Talk

19 mei 2025, 21:50 UTC

Top Nieuws
Winsten

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19 mei 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

19 mei 2025, 20:48 UTC

Top Nieuws

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: R. Brad Martin, Vice Chmn of the FedEx Corp. Bd of Directors, Agreed to Serve as Chmn of the Bd of FedEx Freight >FDX

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: Both Appointments Will Be Effective Upon Completion of the Previously Announced Separation of FedEx Freight From FedEx Corp. >FDX

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: Plans for the Spinoff, Which Is Expected to Occur by June 2026, Remain on Track >FDX

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: Announces Leadership for Independent FedEx Freight Co Upon Separation

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: John A. Smith, Oper Chief, U.S. and Canada, of Federal Express, Has Been Selected as Pres and CEO of FedEx Freight >FDX

19 mei 2025, 20:20 UTC

Top Nieuws

Major U.S. Stock Indexes Finish Higher; Dollar Falls -- WSJ

19 mei 2025, 20:15 UTC

Acquisities, Fusies, Overnames

U.S. Steel Stock Rises on Report of Better Nippon Offer. Why Trump Could Say 'Yes.' -- Barrons.com

19 mei 2025, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

19 mei 2025, 19:59 UTC

Top Nieuws

JPMorgan CEO Dimon Still Intends to Step Down in Next Few Years. 'It's Up to the Board.' -- Barrons.com

19 mei 2025, 19:58 UTC

Marktinformatie

Estonia Redirects Ships After Russia Detains Greek Tanker -- Market Talk

19 mei 2025, 19:52 UTC

Marktinformatie

Imports Accelerate at Southern California Ports -- Market Talk

Peer Vergelijking

Prijswijziging

Bio-Techne Corp Prognose

Koersdoel

By TipRanks

46.92% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 72.4 USD  46.92%

Hoogste 90 USD

Laagste 51 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Bio-Techne Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

7

Buy

4

Hold

0

Sell

Technische score

By Trading Central

49.67 / 50.24Steun & Weerstand

Korte Termijn

Weak Bullish Evidence

Gemiddeld Termijn

Weak Bullish Evidence

Lange Termijn

Strong Bearish Evidence

Sentiment

By Acuity

198 / 382 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company has strategic partnership with ALZpath, Inc. to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.